Nautilus Biotechnology to Participate in the Capital One

SEATTLE, Sept. 23, 2022 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), an organization pioneering a single-molecule protein evaluation platform for quantifying the proteome, at the moment introduced the firm will likely be taking part in the upcoming Capital One Spatial Biology & Proteomics Summit going down just about on Wednesday, September 28, 2022.

Nautilus co-founder and CEO Sujal Patel is scheduled to take part in the following two govt panel discussions:

• Proteomics “Everything You Wanted to Know, But Were Afraid to Ask” at 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
• CEOs from Spatial Biology/Proteomics at 1:00 p.m. Eastern Time / 10 a.m. Pacific Time

Interested events could contact [email protected] to register to attend the digital occasion.

About Nautilus Biotechnology, Inc.
With its company headquarters in Seattle and its analysis and improvement headquarters in the San Francisco Bay Area, Nautilus is a improvement stage life sciences firm making a platform know-how for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to rework the subject of proteomics by democratizing entry to the proteome and enabling basic developments throughout human well being and medication. To be taught extra about Nautilus, go to www.nautilus.bio.

Media Contact
[email protected]

Investor Contact
[email protected]